CompletedNot Applicable

Late Clinical Outcomes of Percutaneous Mitral Commissurotomy in Patients With Mitral Stenosis

Iran220 participantsStarted 2017-03-01

Plain-language summary

In this retrospective cohort study, out of 220 patients who had undergone successful PTMC between 2006 and 2018, the clinical course of 186 patients could be successfully followed. Peri-procedural clinical and echocardiographic data were collected for these patients. Cardiac-related death, undergoing a second PTMC or mitral valve replacement (MVR) were considered adverse cardiac events in follow-up for the purpose of this study. Patients with no history of these events were contacted and asked to undergo echocardiographic imaging, in order to assess the prevalence of mitral valve restenosis, defined as mitral valve area (MVA) \< 1.5 cm2 and loss of ≥50% of initial area gain

Who can participate

Age range35 Years – 52 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * each patient with mitral stenosis undergone successful PTMC Exclusion Criteria: * patient refuse to took part * inability to follow patient

What they're measuring

mitral stenosis

Timeframe: 5.6 years

Trial details

NCT IDNCT04112108

SponsorShiraz University of Medical Sciences

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2018-09-01

View on ClinicalTrials.gov More Mitral Valve Stenosis trials